The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...
The jury's decision marks a victory amid numerous similar cases and highlights debates on formula safety, critical for premature infants. This image is AI-generated and does not depict any real-life ...